Masimo Co. (NASDAQ:MASI) Shares Sold by GSA Capital Partners LLP

GSA Capital Partners LLP lowered its position in shares of Masimo Co. (NASDAQ:MASI - Free Report) by 32.6% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 8,230 shares of the medical equipment provider's stock after selling 3,978 shares during the quarter. GSA Capital Partners LLP's holdings in Masimo were worth $1,097,000 as of its most recent filing with the SEC.

A number of other institutional investors have also modified their holdings of the company. Edgestream Partners L.P. purchased a new position in Masimo in the 2nd quarter worth approximately $645,000. Simplify Asset Management Inc. boosted its holdings in Masimo by 120.4% in the 2nd quarter. Simplify Asset Management Inc. now owns 21,670 shares of the medical equipment provider's stock worth $2,729,000 after acquiring an additional 11,838 shares during the period. State Board of Administration of Florida Retirement System boosted its holdings in Masimo by 11.6% in the 1st quarter. State Board of Administration of Florida Retirement System now owns 54,839 shares of the medical equipment provider's stock worth $8,053,000 after acquiring an additional 5,688 shares during the period. Advisors Asset Management Inc. boosted its holdings in Masimo by 32.1% in the 1st quarter. Advisors Asset Management Inc. now owns 9,009 shares of the medical equipment provider's stock worth $1,323,000 after acquiring an additional 2,187 shares during the period. Finally, Thrivent Financial for Lutherans boosted its holdings in Masimo by 42.1% in the 2nd quarter. Thrivent Financial for Lutherans now owns 1,217,357 shares of the medical equipment provider's stock worth $153,314,000 after acquiring an additional 360,497 shares during the period. Hedge funds and other institutional investors own 85.96% of the company's stock.

Masimo Stock Performance

Shares of MASI stock traded up $0.92 on Friday, hitting $161.07. 544,540 shares of the stock traded hands, compared to its average volume of 679,682. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.01 and a quick ratio of 1.11. The company has a market capitalization of $8.62 billion, a PE ratio of 111.08 and a beta of 0.97. Masimo Co. has a 1-year low of $91.25 and a 1-year high of $173.90. The company's fifty day moving average is $138.18 and its 200 day moving average is $126.95.

Masimo (NASDAQ:MASI - Get Free Report) last posted its quarterly earnings results on Tuesday, November 5th. The medical equipment provider reported $0.98 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.84 by $0.14. The business had revenue of $504.60 million for the quarter, compared to analyst estimates of $502.87 million. Masimo had a return on equity of 14.98% and a net margin of 3.85%. The business's revenue was up 5.4% compared to the same quarter last year. During the same period in the prior year, the company posted $0.63 EPS. On average, equities research analysts predict that Masimo Co. will post 4.04 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the company. Piper Sandler upped their price target on Masimo from $165.00 to $180.00 and gave the stock an "overweight" rating in a report on Wednesday, November 6th. Raymond James raised Masimo from a "market perform" rating to an "outperform" rating and set a $170.00 target price on the stock in a research report on Wednesday, November 6th. Wells Fargo & Company upped their target price on Masimo from $160.00 to $171.00 and gave the company an "overweight" rating in a research report on Wednesday, November 6th. Needham & Company LLC reaffirmed a "hold" rating on shares of Masimo in a research report on Wednesday, November 6th. Finally, BTIG Research upped their target price on Masimo from $166.00 to $170.00 and gave the company a "buy" rating in a research report on Monday, October 14th. Three equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $163.67.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.